Özet:

Purpose: For the protection from thrombembolic events of atrial fibrilation (AF), oral anticoagulant (OAK) start indication is recommended to use OAK in individuals with two or more in the CHA2DS2VASc score system. In the treatment of non-valvular AF patients, the indication of oral anticoagulant use in determination of the use of the CHA2DS2-VASc score along with the use of the ecocardiographic (Epicardial fat tissue (EYD) carotis intima media thickness (KIMK) (aortic propagation velosite) AVP) parameters may be an important target body for the treatment of non-valvular AF. Methods: Non-valvular atrial fibrilation has been diagnosed with more than 100 patients from the age range of 18-90 years. In total, 150 individuals were observed in the study with 50 patients involved in the study for the control group. Patient’s AVP, EYD, KIMK values were performed using the VividE9 eco-cardiography device (Advanced Technology Laboratories) in our eco-cardiography laboratory with 3.0 and 10-MHz tests. Results: The data of our non-study found that the relationship between the epicardial fat tissue and the carotenoid intima media thickness with the CHA2DS2-VASc score was statistically meaningful, not found meaningful with the Aortic Propagation Velocity. Our study requires prospective studies that include a greater number of patients, because the lack of our number of patients may contribute to the detection of a lot of personal and/or processal differences. The result. In the treatment of non-valvular AF patients, the use of CHA2DS2-VASc score in the determination of the indications of oral use of anticoagulant may be an important target organ for the treatment of non-valvular AF and the ecocardiographic (AVP, EYD, KIMK) parameters.

Anahtar Kelimeler: